A complementary team driven by a same goal : build the best screening tool for tuberculosis and diagnose the 4 million people undetected each year !
Epilab is recruiting a senior R&D manager and an R&D assistant, apply below!
We are also looking for motivated and talented people to join our product team!
Get in touch and we will see what you can bring to epilab.
Dr. Lucas Esuh Esong
Member of the PNLT (National program to fight tuberculosis) in Cameroon; consultant for WHO on tuberculosis in Africa and founder of the Always Care Foundation, which promotes access to care and education in underprivileged communities.
Dr. Esuh Esong is well acquainted with the problems associated with field diagnosis and is currently helping EpiLAB organise clinical studies in Central and Sub-Saharan Africa.
Julien Reboud, PhD
Dr Julien Reboud is a Reader in Biomedical Engineering at the University of Glasgow and has an extensive track record in developing and integrating low cost microfluidic systems for measurement of multiple disease states, including in low-resource settings.
After his PhD on new microfluidic technologies for drug screening, Julien worked on new biosensors for medical diagnostics. He then got passionate about translation of new technologies into clinical use and has been awared the RAEng ERA Entrepreneurship Prize (2013). He is currently a co-founder of Acu-Flow Ltd, which won the Scottish Edge in 2019.
Dr. Laurent Raskine
Expert in tuberculosis and international operations for Mérieux Foundation.
His extensive experience in the field and his vast knowledge about the disease disease make him uniquely positioned to guide EpiLAB through scientific research and product development. Laurent Raskine has already set up laboratories and deployed tests in the countries where EpiLAB plans to establish operations, particularly in Africa.
Origin of Epilab
Learn more about our project's creation !
During the first lockdown in March 2020
Clément Dubois is interested in the valorisation of French technologies
He connected with several SATT (technology acceleration and transfer company).From SATT Sayens, the EDMYC process "new portable and easy to use kit for tuberculosis diagnosis" hooked his attention.
With the two technology inventors, Murielle Rochelet, Elodie Barbier, and Maurice Lubetzki, former entrepreneur, they decided to take over the EDMYC patent and created EpiLAB.
Meeting Frédérique Vidal, at Viva Technology event
Viva technology, Europe's biggest startup and tech event, was organised in june 2021 in Paris. Epilab had the opportunity to present its solution on a stand and meet several potential partners.
Special thanks to Frederic Vidal, Minister of Higher Education, Research and Innovation, to whom we presented the EpiLAB solution.
Interview with Epilab at France biotech
France Biotech is the French trade association of biotechnology companies. Its primary mission is to support the development of this industry in France.
Epilab was the subject of the 5th episode of its "Pépites Healthtech" series where France Biotech present promising start-ups.
Epilab in Les Echos
Article in Les Echos, looking back at the beginnings of the start-up and the collaboration with SATT Sayens. Sayens has overseen the maturation of the innovation based on the electrochemical detection of tuberculosis, and now becomes a minor shareholder of the company to help deploy this rapid diagnostic kit on a global scale.
Deeptech Connect event in Paris
Epilab had the opportunity to exchange with the Deeptech ecosystem during the Deeptech Connect. A very interesting day where multiple actors from multiples domains, related to deeptech, gathered.
Epilab joins Cerba Healthcare's virtual incubator
By joining the Virtual Incubator of Cerba HealthCare Group, already widely established in Africa, EpiLAB will be able to accelerate the development of its test and its widespread use. The collaboration with Cerba HealthCare will allow Epilab to propose a product as close as possible to the needs of the field, in order to facilitate its adoption by healthcare professionals and optimize its integration into new patient pathways.
On December 14th was held 13th DemoDay 13 the X-Novation Center from École Polytechnique. EpiLAB had the opportunity to pitch in front of a selected panel of investors and mentors.
Special thanks to the whole ecosystem for the amazing support!
1M€ seed to develop Epilab kit
Epilab raises €1 million to develop its portable, simple and rapid tuberculosis diagnostic kit. This kit will be the first to answer the international's demand for a such a screening tool, and will be deployed in West Africa.
Epilab is selected by SNITEM for the 6th "day of the innovative Startup of the medical device"!
SNITEM (Syndicat National de l'Industrie des Technologies Médicales) is the leading professional organisation representing most of the Medical Devices and Health ICT industryies. It federates more than 500 companies.
Epilab is labeled DeepTech Pioneer by Hello Tomorrow
Hello tomorrow is a mission-driven global organisation that aims to accelerate the transfer of deep technologies to solve some of our most pressing industrial, environmental and societal challenges. For its global summit, they selects start-ups that are game-changers developing cutting-edge technology to bring positive change to our planet, society and industries : DeepTech Pioneers.
Participation in two challenges
EpilAB wins the Prix de l'ingénierie du futur by SYNTEC (https://www.youtube.com/watch?v=k3a0yH9jWDg&ab_channel=Concepteursd%27Avenirs) and reaches the final of the challenge of Centrale Schools
Beginning of The Project
The first meeting between Clément, Maurice, Murielle and Elodie took place in March 2020. Everyone quickly connected and wished to collaborate and put each skill in contribution to develop the portable kit.